Renal vein thrombosis in utero: Duplex sonography in diagnosis and follow-up

1994 ◽  
Vol 24 (2) ◽  
pp. 135-136 ◽  
Author(s):  
J. E. Fishman ◽  
R. C. Joseph
Keyword(s):  
Renal Vein ◽  
Renal Vein Thrombosis ◽  
Duplex Sonography ◽  
In Utero ◽  
Vein Thrombosis

In utero arterial embolism from renal vein thrombosis with successful postnatal thrombolytic therapy

1991 ◽  
Vol 26 (6) ◽  
pp. 741-743 ◽  
Author(s):  
Brian W. Duncan ◽  
N. Scott Adzick ◽  
Michael T. Longaker ◽  
John R. Edwards ◽  
Robert M. Nelson ◽  
...  
Keyword(s):  
Thrombolytic Therapy ◽  
Renal Vein ◽  
Renal Vein Thrombosis ◽  
In Utero ◽  
Arterial Embolism ◽  
Vein Thrombosis

An Attempt to Reach Consensus Regarding Management of Neonatal Renal Vein Thrombosis: The Canadian Pediatric Hemostasis and Thrombosis Network Experience.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4026-4026 ◽  
Author(s):  
L. R. Brandao ◽  
D. Dix ◽  
M. David ◽  
S. Israels ◽  
P. Massicotte ◽  
...  
Keyword(s):  
Renal Vein ◽  
Vena Cava ◽  
Renal Vein Thrombosis ◽  
Therapeutic Approaches ◽  
Vein Thrombosis ◽  
Neonatal Renal Vein Thrombosis ◽  
Frequent Site ◽  
Therapeutic Protocols ◽  
Work Up

Abstract Background: Renal vein thrombosis (RVT) is the most frequent site of primary venous thrombosis in neonates. At present, there is no conventional therapeutic regimen for this condition. Objective: To establish current clinical guidelines based on data from the Canadian Pediatric Hemostasis and Thrombosis Network (CPHTN). Materials and Methods: A standardized questionnaire was sent to CPHTN members involved with pediatric thrombosis care. Clinical variables included thrombus location (unilateral vs. bilateral), severity (non-occlusive vs. occlusive), extension to the inferior vena cava (IVC+), and concomitant bleeding at diagnosis [i.e. hematuria with thrombocytopenia (H/T+), with/without ≥ grade 2 intraventricular hemorrhage (IVH+/−)]. Results: A total of 16 pediatric hematologists participated, with a response rate of approximately 80%. Regarding diagnostic imaging, the most utilized methods were the following: a) Doppler ultrasound (U/S) in 14/16 (87.5%); b) U/S without Doppler in 1/16 (6.25%); and c) contrast venography in 1/16 (6.25%). 12/16 (75%) of the physicians would have ordered a thrombophilia work up. For unilateral, non-occlusive, H/T− or H/T+ cases, management included, respectively: 1) no therapy in 11/16 (68.75%) and 9/16 (56.25%); 2) low-molecular-weight heparin (LMWH) in 2/16 (12.5%) (3-month-course) and 3/16 (18.75%) (14-day or 3-month course); and 3) therapy based on radiologic follow up (f/u) in 3/16 (18.75%) and 4/16 (25%). For unilateral, occlusive, H/T+, IVH− or IVH+ cases, management included: 1) no therapy in 5/16 (31.25%) and 10/16 (62.5%); 2) LMWH in 6/16 (37.5%) and 4/16 (25%); and 3) treatment based on f/u findings in 5/16 (31.25%) and 2/16 (12.5%). For bilateral, occlusive, IVC−, IVH− cases, management included: 1) LMWH (2 weeks to 3 months) in 12/16 (75%); 2) tissue-plasminogen activator (t-PA) in 1/16 (6.25%); 3) LMWH and t-PA in 2/16 (12.5%); and 4) therapy based on f/u in 1/16 (6.25%). Finally, for bilateral, occlusive, IVC+, IVH− or +, the responses were, in that order: 1) LMWH (6 weeks to 3 months) in 10/16 (62.5%) and 11/16 (68.75%); 2) t-PA in 3/16 (18.75%) and 0/16; 3) LMWH and t-PA in 2/16 (12.5%) and 0/16; 4) treatment based on f/u in 1/16 (6.25%) in both groups; 5) no therapy in 2/16 (12.5%) of the latter group only; and 6) unknown in 2/16 (12.5%) of the latter group only. The anti-Xa level (0.5 to 1.0 range) was the only assay suggested for monitoring LMWH. Standard heparin was monitored by anti-Xa levels in only 3/16 (18.75%) of cases. Consultation sources included 1) combined sources (i.e. books, protocols, journals) in 10/16 (62.5%) cases; 2) journals in 4/16 (25%) cases; and 3) 1-800-NO-CLOTS in 2/16 (12.5%) cases. 15/16 (93.75%) of the participating physicians supported the idea of developing therapeutic protocols. Conclusions: Currently, there are no standard therapeutic practices with respect to neonatal RVT. It would be difficult to successfully complete a randomized clinical trial due to small numbers. However, multicenter, prospective studies utilizing consistent therapeutic approaches would be extremely helpful in this clinical setting.

Radiological Manifestations of Neonatal Renal Vein Thrombosis on Follow-Up Examinations

Radiology ◽  
1977 ◽  
Vol 122 (2) ◽  
pp. 435-438 ◽  
Author(s):  
Tudor J. Sutton ◽  
Antoine Leblanc ◽  
Noëlle Gauthier ◽  
Max Hassan
Keyword(s):  
Renal Vein ◽  
Renal Vein Thrombosis ◽  
Vein Thrombosis ◽  
Neonatal Renal Vein Thrombosis

Clinical Characteristics and Long-term Follow-up of Patients With Renal Vein Thrombosis

2008 ◽  
Vol 51 (2) ◽  
pp. 224-232 ◽  
Author(s):  
Waldemar E. Wysokinski ◽  
Izabela Gosk-Bierska ◽  
Eddie L. Greene ◽  
Diane Grill ◽  
Heather Wiste ◽  
...  
Keyword(s):  
Renal Vein ◽  
Clinical Characteristics ◽  
Renal Vein Thrombosis ◽  
Vein Thrombosis ◽  
Long Term Follow Up

scholarly journals Endarterectomy for Iliac Occlusive Disease during Kidney Transplantation: A Multicenter Experience

2020 ◽  
Author(s):  
William S. Sorrells ◽  
Shennen A. Mao ◽  
Timucin Taner ◽  
Caroline C. Jadlowiec ◽  
Houssam Farres ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Kidney Transplantation ◽  
Vascular Surgery ◽  
Iliac Artery ◽  
Renal Vein ◽  
Perioperative Complications ◽  
Renal Vein Thrombosis ◽  
Allograft Survival ◽  
Vein Thrombosis

AbstractLittle is known about the surgical challenges and outcomes of kidney transplantation (KT) in the face of severe iliac occlusive disease (IOD). We aim to examine our institution's experience and outcomes compared with all KT patients. Retrospective review of our multi-institutional transplant database identified patients with IOD requiring vascular surgery involvement for iliac artery endarterectomy at time of KT from 2000 to 2018. Clinical data, imaging studies, and surgical outcomes of 22 consecutive patients were reviewed. Our primary end-point was allograft survival. Secondary end-points included mortality and perioperative complications. A total of 6,757 KT were performed at our three sites (Florida, Arizona, and Minnesota); there were 22 (0.32%) patients receiving a KT with concomitant IOD requiring iliac artery endarterectomy. Mean patient age was 61.45 ± 7 years. There were 13 (59.1%) male patients. The most common etiology of renal failure was diabetic nephropathy in 10 patients (45.5%) followed by a combination of hypertensive/diabetic nephropathy in five patients (22.7%), and hypertensive nephrosclerosis in three patients (13.6%). The majority (n = 16, 72.7%) of patients received renal allografts from deceased donors and six (27.3%) were recipients from living donors. Mean time from dialysis to transplantation was 2.9 ± 2.9 years. Mean follow-up was 3.5 ± 2.5 years. Mean length of hospital stay was 6.3 ± 4.3 days (range: 3–18 days). Graft loss within 90 days occurred in two (9.1%) patients, one due to renal vein thrombosis and another due to acute tubular necrosis. Overall allograft survival was 90.1% at 1-year and 86.4% at 3-year follow-up. Overall mortality occurred in 6 (27.3%) patients. Perioperative complications (Clavien-Dindo Grade 2–4) occurred in 13 (59.1%) patients, including 10 (45.5%) with acute blood loss anemia requiring transfusion, 2 (9.1%) reoperations for hematoma evacuation, 1 (4.5%) ischemic colitis requiring total abdominal colectomy, and 1 (4.5%) renal vein thrombosis requiring nephrectomy. IOD patients selected for KT are not common and although challenging, they have similar outcomes to our standard KT patients. The 1- and 3-year allograft survivals were 90.1 and 86.4% versus 96.0 and 90.3% in the general KT patient population. With these excellent outcomes, we recommend expanding the criteria for KT to include patients with IOD with prior vascular surgery consultation to prevent progression of IOD or prevention of wait list removal in select patients who are otherwise good candidates for KT.

scholarly journals A case report of renal vein thrombosis following whiplash by husband with review article

2019 ◽  
Vol 9 (1) ◽  
pp. 07-07
Author(s):  
Telma Zahirian Moghadam ◽  
Hamed Mohseni Rad
Keyword(s):  
Renal Vein ◽  
Arterial Injury ◽  
Renal Vein Thrombosis ◽  
Emergency Center ◽  
Vein Thrombosis ◽  
Renal Vessel ◽  
Whiplash Trauma ◽  
The Right ◽  
Fat Stranding

Renal vessel thrombosis results in kidney loss unless be re-vascularized immediately. We report a case of right renal vein thrombosis in a 43 years old woman following whiplash trauma by her husband without any associated parenchymal or arterial injury. She presented to our emergency center with right flank pain for three days. She reported whiplashing by her husband 3 days before admission. Abdominopelvic spiral computerized tomography (CT) with intra-venous contrast showed a non-enhancement, enlargement and peri-renal fat-stranding in the right kidney. With the diagnosis of renal vein thrombosis following whiplash, the patient was heparinized 5000 IU sub-cutaneous every 8 hours and discharged with warfarin after resolution of gross hematuria. Follow-up with nuclear scan 10 weeks later showed the right kidney is non-function.

Noninvasive Diagnosis and follow-up of Childhood Renal Vein Thrombosis by Ultrasound, Doppler, and Renal Scintiscan

1985 ◽  
Vol 9 (2) ◽  
pp. 305-313 ◽  
Author(s):  
Chan H. Park ◽  
Ruth P. Gottlieb ◽  
Hyung S. Yoo ◽  
Matthew E. Pasto
Keyword(s):  
Renal Vein ◽  
Renal Vein Thrombosis ◽  
Noninvasive Diagnosis ◽  
Ultrasound Doppler ◽  
Vein Thrombosis

scholarly journals PO-0609 Disseminated Renal Vein Thrombosis May Begin In Utero

2014 ◽  
Vol 99 (Suppl 2) ◽  
pp. A452.2-A452
Author(s):  
S Aktas ◽  
S Unal ◽  
C Turkyilmaz ◽  
C Damar ◽  
B Derinkuyu ◽  
...  
Keyword(s):  
Renal Vein ◽  
Renal Vein Thrombosis ◽  
In Utero ◽  
Vein Thrombosis
Sign in / Sign up

Export Citation Format

Share Document